Hedge Fund - Octagon Capital Advisors
Bridgebio Pharma Inc. (BBIO)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $0 | 0% | 0 | $33.72 |
| 2 | 2024 - Q4 (2024-12-31) | $12,117,504 | 1.99% | 441,600 | $25.84 |
| 3 | 2024 - Q3 (2024-09-30) | $14,053,920 | 2.18% | 552,000 | $26.25 |
| 4 | 2024 - Q2 (2024-06-30) | $17,477,700 | 2.74% | 690,000 | $27.34 |
| 5 | 2024 - Q1 (2024-03-31) | $21,334,800 | 2.55% | 690,000 | $34.01 |
| 6 | 2023 - Q4 (2023-12-31) | $28,533,516 | 4.56% | 706,800 | $30.03 |
| 7 | 2023 - Q3 (2023-09-30) | $25,622,120 | 3.93% | 971,639 | $28.38 |
| 8 | 2023 - Q2 (2023-06-30) | $20,970,240 | 2.91% | 1,219,200 | $15.05 |
| 9 | 2023 - Q1 (2023-03-31) | $22,186,693 | 3.19% | 1,338,160 | $11.66 |
| 10 | 2022 - Q4 (2022-12-31) | $7,115,122 | 1.1% | 933,743 | $9.57 |
| 11 | 2022 - Q3 (2022-09-30) | $9,281,000 | 1.6% | 933,743 | $10.39 |
| 12 | 2022 - Q2 (2022-06-30) | $8,478,000 | 2.26% | 933,743 | $8.36 |
| 13 | 2022 - Q1 (2022-03-31) | $23,015,000 | 4.97% | 2,267,486 | $10.26 |
| 14 | 2021 - Q4 (2021-12-31) | $29,482,000 | 5.73% | 1,767,486 | $42.31 |
| 15 | 2021 - Q3 (2021-09-30) | $26,688,000 | 6.57% | 569,414 | $53.60 |
| 16 | 2021 - Q2 (2021-06-30) | $23,221,000 | 4.8% | 380,928 | $57.11 |
The displayed share prices are average quarterly stock market prices.
Hedge Fund Resource Center